Treatment of vesico-ureteral reflux in infants and children using endoscopic approaches. [PDF]
Transl Pediatr, 2016 Vesicoureteral reflux (VUR) represents one of the most significant risk factors for acute pyelonephritis in children. Endoscopic treatment of VUR dates back to 1981 when Matouschek first described injection of the ureteral orifice in an attempt to ...
Okawada M +6 more
europepmc +5 more sources
Durasphere® EXP: a non-biodegradable agent for treatment of primary Vesico-Ureteral reflux in children [PDF]
International Brazilian Journal of Urology, 2018 Introduction: Durasphere® EXP (DEXP) is a compound of biocompatible and non--biodegradable particles of zirconium oxide covered with pyrolytic carbon.
Unsal Ozkuvanci +5 more
doaj +4 more sources
Chromosome 18q-syndrome and 1p terminal duplication in a patient with bilateral vesico-ureteral reflux: case report and literature revision. [PDF]
Ital J Pediatr, 2013 Background: Vesico-ureteral reflux (VUR) is a dynamic event in which a retrograde flow of urine is present into the upper tracts. VUR may occur isolated or in association with other congenital abnormalities or as part of syndromic entities.
Brandigi E +5 more
europepmc +7 more sources
Physiopathology of vesico-ureteral reflux. [PDF]
Ital J Pediatr, 2016 Vescico-Ureteral Reflux (VUR) is a common condition in childhood, caused by a congenital anomaly at the Vescico-Ureteral Junction (VUJ) level. It seems that the main cause could be an abnormal embryological development occurred during the early stage of fetal life.Refluxing ureteral endings show structural and functional anomalies: previous studies ...
Arena S +6 more
europepmc +5 more sources
Uromodulin and Vesico-Ureteral Reflux: A Genetic Study [PDF]
Biomedicines, 2023 Vesicoureteral reflux (VUR) is associated with urinary tract infections (UTI) and renal scars. The kidney damage is correlated with the grade of reflux and the number of UTI, but other factors may also play a role. Uromodulin (UMOD) is a protein produced
Silvio Maringhini +8 more
doaj +2 more sources
Endoscopic treatment of vesicoureteral reflux in pediatric patients [PDF]
Korean Journal of Pediatrics, 2013 Endoscopic treatment is a minimally invasive treatment for managing patients with vesicoureteral reflux (VUR). Although several bulking agents have been used for endoscopic treatment, dextranomer/hyaluronic acid is the only bulking agent currently ...
Jong Wook Kim, Mi Mi Oh
doaj +4 more sources
Urinary excretion of EGF and MCP-1 in children with vesico-ureteral reflux [PDF]
International Brazilian Journal of Urology, 2017 Purpose The aim of this study was to investigate the urinary concentration of epidermal growth factor (EGF) and monocyte chemotactic protein-1 (MCP-1) as reflux nephropathy (RN) biomarkers before and after endoscopic treatment of moderate to severe ...
Valentina Pastore, Fabio Bartoli
doaj +2 more sources
Risk factors for obstructive complications after endoscopic correction of vesico-ureteral reflux using polyacrylate polyalcohol copolymer. [PDF]
Medicine (Baltimore), 2020 Sizonov VV +6 more
europepmc +2 more sources
Endoscopic treatment of vesico-ureteral reflux: Experience of 99 ureteric moieties
Journal of Indian Association of Pediatric Surgeons, 2013 Aims: To study the outcome of endoscopic hyaluronic acid/dextranomer injection in patients with vesico-ureteric reflux (VUR). Materials and Methods: Sixty-three children were evaluated with a median follow up of 18 months (12-55 months) before injecting ...
Minu Bajpai +2 more
doaj +2 more sources